Fidelity Investments’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-569,336
Closed -$7.86M 2728
2017
Q1
$7.86M Sell
569,336
-136,364
-19% -$2.19M ﹤0.01% 2046
2016
Q4
$13.4M Hold
705,700
﹤0.01% 1855
2016
Q3
$15.7M Sell
705,700
-11,000
-2% -$207K ﹤0.01% 1797
2016
Q2
$13.1M Sell
716,700
-181,700
-20% -$3.13M ﹤0.01% 1849
2016
Q1
$16.3M Hold
898,400
﹤0.01% 1769
2015
Q4
$15.1M Sell
898,400
-39,159
-4% -$665K ﹤0.01% 1811
2015
Q3
$16.9M Sell
937,559
-322,317
-26% -$7.18M ﹤0.01% 1713
2015
Q2
$32.6M Buy
1,259,876
+258,100
+26% +$6.52M ﹤0.01% 1531
2015
Q1
$21.9M Buy
+1,001,776
New +$21.6M ﹤0.01% 1697

Other funds holding ENTL

Fidelity Investments's ENTL Position: Q2 2017 in Review

Fidelity Investments sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q2 2017, closing a stake of 569,336 shares — an estimated $7.86M sold.

Fidelity Investments first reported a position in ENTL in Q1 2015 and held it in 9 quarters. The position peaked at $32.6M in Q2 2015. 73 funds tracked by Wall St. Rank hold ENTL as of Q2 2017.

  • Fidelity Investments reported no remaining Entellus Medical, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
  • Fidelity Investments sold 569,336 Entellus Medical, Inc. Common Stock shares in Q2 2017, an estimated $7.86M.
  • Fidelity Investments first reported a position in Entellus Medical, Inc. Common Stock in Q1 2015 and held it in 9 quarters.
  • Fidelity Investments's Entellus Medical, Inc. Common Stock position peaked at $32.6M in Q2 2015.
  • 73 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q2 2017.

Based on Fidelity Investments's 13F filing for Q2 2017, filed 11 Aug 2017.